Dave Lee in

Dave Lee

Login to view DISC.
Executive Director, Supply Chain at REVOLUTION Medicines
📍 Palo Alto, California, United States

Dave Lee is the Executive Director of Supply Chain at REVOLUTION Medicines, leading end-to-end supply chain operations. With over a decade of experience in the biopharma industry and an MBA from UCLA Anderson School of Management, he specializes in aligning supply chain strategy with clinical and commercial objectives.

While at Amgen, he was accountable for managing commercial partnerships valued at approximately $200 million per year.

Read the full overview →
Experience
16 Years
Current Role
Executive Director, Supply Chain
Job Level
Senior
Location
Palo Alto, California, United States
Personality Overview

How Dave shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Dave cares about

Pharma Supply Chain
He has over a decade of experience managing clinical and commercial supply chains for companies like Amgen, Astellas Gene Therapies, and REVOLUTION Medicines.
Commercial Readiness
He focuses on readiness for commercialization at REVOLUTION Medicines and previously led commercial supply readiness for a key product at Astellas Gene Therapies.
+5 more topics Login to view topics
Career

Work history

3-2024
Executive Director, Supply Chain
REVOLUTION Medicines
7-2022 - 2-2024
Senior Director, Clinical Supply Chain
REVOLUTION Medicines
11-2020 - 7-2022
Director, Commercial and Clinical Supply
Astellas Gene Therapies
5-2018 - 11-2020
Senior Associate Director/Associate Director, Bio Product Mgmt Ops & Third-Party Mgmt
Boehringer Ingelheim
11-2014 - 4-2018
Senior Manager, Global Supply Chain
Amgen
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
2005 - 2008
Master of Business Administration (M.B.A.)
UCLA Anderson School of Management
1996 - 2003
MS/BS
UCLA
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

Other REVOLUTION Medicines Employees

Explore more public profiles from related professionals.

Katie Ditmore Sinaikin
Katie Ditmore Sinaikin
Executive Director, Global Analytics and Insights
Revolution Medicines
 Camellia Lock
Camellia Lock
Associate Director, Marketing
Revolution Medicines
 Lisa Graup
Lisa Graup
Executive Director of Marketing, Oncology
Revolution Medicines
 Kimberly Martinez
Kimberly Martinez
Senior Manager, Contract Optimization and Strategy Team - Clinical Operations
Revolution Medicines

More profiles

Discover additional public profiles from our index.

TM
Tim Mitchell
Senior Director, Data
Neogen Corporation
 Kenny Speer
Kenny Speer
Vice President of Software Engineering
Guardant Health
 Greg Delowery
Greg Delowery
Data Strategy & Governance
Integrated DNA Technologies
RG
Ronak G.
Director of Embedded System
Inogen
Unlock the full playbookSee exactly how to sell to Dave. Free, 10 seconds.